Phase I/II Study AC6 Gene Transfer for Congestive Heart Failure

Trial Profile

Phase I/II Study AC6 Gene Transfer for Congestive Heart Failure

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Nov 2016

At a glance

  • Drugs RT 100 (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2016 According to a Renova Therapeutics media release, company has submitted trial results to the FDA.
    • 30 Mar 2016 According to a Renova Therapeutics media release, results from this study will be published in the April 2016 print issue of JAMA Cardiology.
    • 30 Mar 2016 Results were published in a Renova Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top